Letaxaban
Letaxaban (TAK-442) is an orally active and selective direct FXa inhibitor. Letaxaban is a drug with dual anticoagulant and anti-inflammatory activity that works by directly inhibiting FXa and by intervening in the PAR1 signaling pathway. Letaxaban can be used in the study of thrombotic diseases, cardiovascular diseases and inflammation-related diseases[1].
Product Specifications
CAS Number
870262-90-1
Product Name Alternative
TAK-442
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Factor Xa
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/letaxaban.html
Smiles
ClC1=CC2=C(C=C1)C=C(C=C2)S(C[C@@H](O)C(N3CCC(N4C(NCCC4)=O)CC3)=O)(=O)=O
Molecular Formula
C22H26ClN3O5S
Molecular Weight
479.98
Precautions
P261-P280-P302+P352
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MYP Agar, Base (B/S) (Phenol Red Egg Yolk Polymyxin Agar, Base)
Amylose Separopore® 4B-CL (Divinyl Sulfone-Coupled)
PEPD (Proline Dipeptidase, Prolidase) (MaxLight 650)
PEPD (Proline Dipeptidase, Prolidase) (MaxLight 650)
KCNK6, CT (KCNK6, TOSS, TWIK2, Potassium channel subfamily K member 6, Inward rectifying potassium channel protein TWIK-2, TWIK-originated similarity sequence)